1. Are BRCA2 gene mutation patients inappropriately under-screened for pancreatic adenocarcinoma?. (April 2017) Authors: Roch, A.M.; Johnston, M.E.; Schneider, J.; Hunter, J.L.; Lancaster, W.P.; House, M.G.; Zyromski, N.J.; Nakeeb, A.; Schmidt, C.M.; Ceppa, E.P. Journal: HPB Issue: Volume 19(2017)Supplement 1 Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association of intraductal papillary mucinous neoplasm and pancreatic neuroendocrine tumors: myth or reality?. (April 2017) Authors: Schmidt, C.; Roch, A.M.; Carr, R.A.; Bletsis, P.; Lancaster, W.P.; House, M.G.; Zyromski, N.J.; Nakeeb, A.; Ceppa, E.P.; Schmidt, C.M. Journal: HPB Issue: Volume 19(2017)Supplement 1 Page Start: S76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Splenic involvement in pancreatic adenocarcinoma may carry significant clinical impact. (April 2017) Authors: Ramanathan, K.; Carr, R.A.; Roch, A.M.; Lancaster, W.P.; Ceppa, E.P.; House, M.G.; Zyromski, N.J.; Nakeeb, A.; Schmidt, C.M. Journal: HPB Issue: Volume 19(2017)Supplement 1 Page Start: S161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The effect of goal-directed fluid administration on outcomes after pancreatic surgery. (March 2019) Authors: Lancaster, W.P.; Adams, D.B.; Morgan, K.A. Journal: HPB Issue: Volume 21(2019)Supplement 1 Page Start: S49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗